1-4 of 4
Federica Piccioni
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Acquired FGFR and FGF Alterations Confer Resistance to Estrogen Receptor (ER) Targeted Therapy in ER+ Metastatic Breast Cancer

Pingping Mao, Ofir Cohen, Kailey J. Kowalski, Justin G. Kusiel, Jorge E. Buendia-Buendia, Michael S. Cuoco, Pedro Exman, Seth A. Wander, Adrienne G. Waks, Utthara Nayar, Jon Chung, Samuel Freeman, Orit Rozenblatt-Rosen, Vincent A. Miller, Federica Piccioni, David E. Root, Aviv Regev, Eric P. Winer, Nancy U. Lin, Nikhil Wagle
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (22): 5974–5989.
https://doi.org/10.1158/1078-0432.CCR-19-3958
Published: 13 November 2020
View article titled, Acquired FGFR and FGF Alterations Confer Resistance to Estrogen Receptor (ER) Targeted Therapy in ER<sup>+</sup> Metastatic Breast Cancer
Open the PDF for Acquired FGFR and FGF Alterations Confer Resistance to Estrogen Receptor (ER) Targeted Therapy in ER<sup>+</sup> Metastatic Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract AP14: POOLED GENOMIC SCREENS IDENTIFY ANTI-APOPTOTIC GENES AS MEDIATORS OF CHEMOTHERAPY RESISTANCE IN OVARIAN CANCER

Elizabeth H. Stover, Maria B. Baco, Ofir Cohen, Yvonne Li, Elizabeth Christie, Mukta Bagul, Amy Goodale, Yenarae Lee, Sasha Pantel, Matthew Rees, Guo Wei, Adam Presser, Ioannis Zervantonakis, Patrick Bhola, Jeremy Ryan, Jennifer Guerriero, Felice Liang, Andrew Cherniack, Federica Piccioni, Ursula A. Matulonis, David D. L. Bowtell, Anthony Letai, Kris Sarosiek, Levi Garraway, Cory M. Johannessen, Matthew Meyerson
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (22_Supplement): AP14.
https://doi.org/10.1158/1557-3265.OVCASYMP18-AP14
Published: 15 November 2019
View article titled, Abstract AP14: POOLED GENOMIC SCREENS IDENTIFY ANTI-APOPTOTIC GENES AS MEDIATORS OF CHEMOTHERAPY RESISTANCE IN OVARIAN CANCER
Journal Articles

A Combination CDK4/6 and IGF1R Inhibitor Strategy for Ewing Sarcoma

Lillian M. Guenther, Neekesh V. Dharia, Linda Ross, Amy Conway, Amanda L. Robichaud, Jerrel L. Catlett, II, Caroline S. Wechsler, Elizabeth S. Frank, Amy Goodale, Alanna J. Church, Yuen-Yi Tseng, Rajarshi Guha, Crystal G. McKnight, Katherine A. Janeway, Jesse S. Boehm, Jaume Mora, Mindy I. Davis, Gabriela Alexe, Federica Piccioni, Kimberly Stegmaier
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (4): 1343–1357.
https://doi.org/10.1158/1078-0432.CCR-18-0372
Published: 15 February 2019
View article titled, A Combination CDK4/6 and IGF1R Inhibitor Strategy for Ewing Sarcoma
Open the PDF for A Combination CDK4/6 and IGF1R Inhibitor Strategy for Ewing Sarcoma in another window
Includes: Supplementary data
Journal Articles

Abstract PR5: Identifying mechanisms of drug resistance to MAPK pathway inhibition via genome-scale rescue screens

Cory M. Johannessen, Laura A. Johnson, Daniel Lam, Luke Hamm, Federica Piccioni, David Root, Levi Garraway
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (10_Supplement): PR5.
https://doi.org/10.1158/1078-0432.MECHRES-PR5
Published: 04 March 2013
View article titled, Abstract PR5: Identifying mechanisms of drug resistance to MAPK pathway inhibition via genome-scale rescue screens
Open the PDF for Abstract PR5: Identifying mechanisms of drug resistance to MAPK pathway inhibition via genome-scale rescue screens in another window